Companies / United Arab Emirates
DuBiotech Gets Its First CRO
November 2007 | Company News AlertCROs are expanding rapidly on the back of the trend for major pharmaceutical firms to outsource various phases of the drug development process. The worldwide R&D spend on CROs was estimated at US$14bn in 2005, representing 25% if the pharmaceutical industry's total R&D spend. BMI expects this proportion to grow as multinationals look to increasingly outsource clinical trials to emerging markets with lower costs, and consequently look for partners with local
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
